Contradictory results in favor or against the pro-inflammatory effect of these products consumption in humans were published [151]
Contact us today to schedule a consultation and start your path to a healthier, happier you
Clinical Evidence & Research Findings The published research behind AOD-9604 and Tesamorelin tells two very different stories: AOD-9604s early efficacy signal didnt hold up in its largest trial, while Tesamorelins did which is the central reason one reached FDA approval and the other didnt
Optimize your performance, recovery, and longevity with the CJC/Ipamorelin peptide protocol
Individuals with certain health conditions should not use GLP-1 medications, regardless of the dose
(accessed June 2022) 13Buse JB, Wexler DJ, Tsapas A, et al